Evidence map›Paper›PMID 33687066›Full record

ReviewEuropean journal of immunology2021

Insights into coronavirus immunity taught by the murine coronavirus.

Sarah Grabherr, Burkhard Ludewig, Natalia Barbara Pikor

Open access · bronzeAbstract readReview
In one paragraph

Review in European journal of immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. T cell responses to SARS-CoV-2 in humans and animals.Journal of microbiology (Seoul, Korea) · 2022
    Review
  12. Article
  13. Cross-species transmission, evolution and zoonotic potential of coronaviruses.Frontiers in cellular and infection microbiology · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sarah GrabherrInstitute of Immunobiology, Medical Research Center, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Burkhard LudewigInstitute of Immunobiology, Medical Research Center, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID 0000-0002-7685-573X
Natalia Barbara PikorInstitute of Immunobiology, Medical Research Center, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID 0000-0002-6564-4232
Kantonsspital St. Gallen · CHUniversity of Zurich · CH

Funding

the Novartis Foundation for Biomedical Researchthe Swiss National Science Foundation 177208the Swiss National Science Foundation 180011the Swiss National Science Foundation 182583
6 · The paper itself

Abstract

Coronaviruses (CoVs) represent enveloped, ss RNA viruses with the ability to infect a range of vertebrates causing mainly lung, CNS, enteric, and hepatic disease. While the infection with human CoV is commonly associated with mild respiratory symptoms, the emergence of SARS-CoV, MERS-CoV, and SARS-CoV-2 highlights the potential for CoVs to cause severe respiratory and systemic disease. The devastating global health burden caused by SARS-CoV-2 has spawned countless studies seeking clinical correlates of disease severity and host susceptibility factors, revealing a complex network of antiviral immune circuits. The mouse hepatitis virus (MHV) is, like SARS-CoV-2, a beta-CoV and is endemic in wild mice. Laboratory MHV strains have been extensively studied to reveal coronavirus virulence factors and elucidate host mechanisms of antiviral immunity. These are reviewed here with the aim to identify translational insights for SARS-CoV-2 learned from murine CoVs.

Indexed as

Adaptive ImmunityAnimalsCoronavirus InfectionsDisease Models, AnimalHumansMiceMiddle East Respiratory Syndrome CoronavirusMurine hepatitis virusSARS-CoV-2Severe acute respiratory syndrome-related coronavirusSeverity of Illness IndexSpike Glycoprotein, CoronavirusViral TropismSpike Glycoprotein, CoronavirusAnimal modelsHost/pathogen interactionImmune responsesMouse Hepatitis VirusSARS-CoV-2

Identifiers

PMID33687066
PMCPMC8250324
OpenAlexW3135061674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.